ISTH 2020 Congress Archives - ISTH Congress Abstracts

Abstract Number: PB2540

F1+2 in Preeclampsia: Is it a Good Hemostatic Marker?

L. Dusse, P. Alpoim, M. Carvalho
Abstract Number: PB0688

Factor V inhibitor in a patient with Strongyloides Stercolaris and antibiotic therapy

E. Sueldo¹, M. Cermelj², M.D.V. Arias³
Abstract Number: PB0053

Factor V Leiden but Not Factor II 20210G>A Is a Risk Factor in a Large Cohort of Iranian Patients with Premature Coronary Artery Disease

I. Mancini¹, S. Sadeghian², M.T. Pagliari³, S.H. Abbasi^2,4, H. Poorhosseini², M.A. Boroumand², M. Lotfi-Tokaldany², E. Pappalardo¹, G. Colombo¹, F. Tafuri¹, P. Agosti¹, F.R. Rosendaal⁵, F. Peyvandi^1,3
Abstract Number: PB2052

Factor V Leiden Is Associated with Atrial Fibrillation, but Not Ischemic Stroke in Atrial Fibrillation. The Tromsø Study

E.M. Hald¹, M.-L. Løchen², E.B. Mathiesen³, I. Njølstad², S.K. Brækkan¹, J.-B. Hansen¹
Abstract Number: PB0836

Factor VIII Does Not Elicit Danger Signals to Innate Immune Cells in Vivo

M.C. Cormier, K. Nesbitt, P. Batty, C. Hough, D. Lillicrap
Abstract Number: PB1076

Factor VIII trough Levels in Patients with Hemophilia A on Secondary Prophylaxis in Relation to Clinical and Radiological Outcomes

A. Tantawy, I. Ragab, M. Khalil, S. Mostafa
Abstract Number: PB1946

Factor VIII/Protein C and Not ADAMTS13/VWF:Ag Ratio Is a Prognostic Risk Factor for Patients with Cirrhosis and Low MELD Score

N. Bitto¹, G. Tosetti², A. Tripodi³, I. Mancini⁴, L. Baronciani³, C. Valsecchi³, P. Lampertico², F. Peyvandi^1,3, M. Primignani², V. La Mura^1,2
Abstract Number: PB0171

Factor Xa Stimulates PAR-Independent Pro-Inflammatory Responses in Primary Adult Rat Cardiac Fibroblasts

E. D'Alessandro¹, B. Scaf², C. Munts², S. Verheule², R. van Oerle¹, H. Spronk^1,3, H. ten Cate^1,3, U. Schotten², F. van Nieuwenhoven²
Abstract Number: PB0251

Factor XII and Kininogen Complex with gC1qR/C1QBP/P32 Is Governed by Zinc Ions

J. Emsley¹, B. Kaira¹, A. Slater¹, K. Mccrae², S. Ummay³, N. Mutch³, M. Searle⁴
Abstract Number: PB0185

Factor XII Deficiency – A Very Rare Coagulation Disorder: Case Report

D. Stambolieva¹, M. Shorova^2,3, T. Malinova^1,4, S. Ortakovska^5,6, V. Gjorgjevska^7,8
Abstract Number: PB0726

Factor XIII Cross-Links Fibrin(ogen) Independent of Fibrin Polymerization in Experimental Acute Liver Injury

L.G. Poole^1,2, A.K. Kopec¹, D.J. Groeneveld¹, A. Pant¹, K.S. Baker^2,3, H.M. Cline-Fedewa¹, M.J. Flick⁴, J.P. Luyendyk^1,2,3
Abstract Number: PB0731

Factor XIII-A Is Present within Organelles Known to Mediate Unconventional Protein Secretion

P. Cordell¹, R. Pease²
Abstract Number: PB0715

Factor XIIIa-Mediated Red Blood Cell Retention in the Contracting Clot Is Impaired in Hereditary Dysfibrinogenemia

R. Marchi^1,2, F. Macrae³, M. Neerman-Arbez⁴, P. Fontana², R. Ariëns³, A. Casini²
Abstract Number: PB2348

Factors Associated with Major Bleeding Risk in Medical and Surgical Patients: Findings from a Multi-Center, Cross-Sectional Study (DissolVE-2)

Z. Zhang¹, Z.-G. Zhai¹, X.-Y. Qin², Y.-K. Shi³, R.-H. Xu⁴, W.-M. Li⁵, Y.-M. Xu⁶, J.-M. Qu^7,8, C. Wang¹
Abstract Number: PB1345

Factors Influencing Bleeding Severity in Adult Patients with Primary Immune Thrombocytopenia

J. Gebhart¹, M. Fillitz², B. Dixer², L. Buresch¹, A. Rath¹, C. Ay¹, I. Pabinger¹
Abstract Number: PB2130

Failure of the Ottawa Score to Predict the Risk of Recurrent Venous Thromboembolism in Patients with Cancer-Associated Thrombosis. A Pooled Analysis of two Prospective Cohort Studies

C. Chapelle^1,2, P. Girard^3,4, B. Planquette⁵, S. Acassat¹, N. Falvo^4,6, A. Lamblin⁷, S. Laporte^1,2,4, G. Meyer^4,8, aXa and PREDICARE investigators
Abstract Number: PB0469

Familial Thrombophilia of Unknown Origin (TUO) Is Associated with Low Activated Protein C (APC) Response to in vivo Thrombin Formation in Stimulated Hemostasis Activity Pattern Evaluation (SHAPE)

H. Rühl, S. Reda, F.I. Winterhagen, C. Berens, J. Müller, J. Oldenburg, B. Pötzsch
Abstract Number: PB2567

Family History of Preeclampsia and Hypertension: A Predictor of Preeclampsia in a Resource Limited Country

F.F. Khidri¹, A.M. Waryah²
Abstract Number: PB1845

Fat Emulsion for Parental Nutrition as Well as Lipid Emulsion of the Drug Propofol Strongly Enhance Platelet Activation Induced by Human Albumin, Misfolded by Structural Modification with the Granulocyte Defence Weapon HOCl

A.G. Herminghaus, M.F. Brodde, B.E. Kehrel
Abstract Number: PB2065

Fatal Intracerebral Hemorrhage in a Patient on Warfarin: A Case Report

A.B.R. Rosa¹, M.F.S. Praxedes², B.C.S. Almeida¹, A.F. Medeiros³, A.L. Ribeiro¹, M.A.P. Martins^1,4
Abstract Number: PB0907

Favourable Outcomes in Two Young Patients with Severe Haemophilia B After Switching to rIX-FP

G. Sottilotta¹, F. Luise¹, G.M. Nicolò², V. Oriana¹, A. Piromalli¹
Abstract Number: PB0662

Feasibility of a Universal Calibrator for Direct FXa Inhibitor DOACs

S. Geiter, M. Unterberger, N.B. Binder
Abstract Number: PB1074

Feasibility of Implementation of Point-of-Care Musculoskeletal Ultrasound in Joint Status Assessment in Children with Hemophilia

O. Khan¹, L. Malec², A. Rafique³, A. Wood³, M. Brakefield¹, S. Akins⁴, T. Kaltenmark⁴, N. Bakeer⁴
Abstract Number: PB0840

Feasibility of Using Hospital Episode Statistics in England to Assess the Resource Use and Outcomes in Haemophilia

G. Morgan¹, S. Kar², N. Misciattelli², J. O'Hara^1,3, T. Burke¹
Abstract Number: PB1258

Features of Epistaxis Predictive of a Mucocutaneous Bleeding Disorder (MBD) in Children

M. Rand¹, C. Lee¹, D. Stephens¹, P. James², V. Blanchette¹
Abstract Number: OC 08.2

Features of Hematopoietic Stem and Progenitor Cells Identified through Single-Cell RNA Sequencing in Immune Thrombocytopenia

A. Liu, S. Wang, Q. Feng, J. Peng
Abstract Number: PB1752

Feedback Inhibition of Human Platelet Syk by PKC-caused Syk S297 Phosphorylation

S. Makhoul¹, S. Dorschel¹, S. Gambaryan^1,2, O. Pagel³, R.P. Zahedi⁴, U. Walter¹, K. Jurk¹
Abstract Number: PB0951

Females with Haemophilia in Nordic Countries Have a Higher Risk of Developing Pain, Anxiety and Depression Based on Treatment Patterns as Compared to Matched Controls: Data from a Registry Study over a Period of 11 Years

K. Steen Carlsson^1,2, B. Winding³, J. Astermark⁴, F. Baghaei⁵, E. Brodin⁵, E. Funding⁶, M. Holmström⁷, K. Österholm⁸, S. Bergenstråle³, E. Andersson¹, S. Lethagen^3,9
Abstract Number: PB2556

Fertility Issues in Women with Inherited Bleeding Disorders

O. Kaabia¹, M. Derouiche¹, R. Bouchahda¹, B. Achour², M. Bibi¹
Abstract Number: PB1748

Fibrillar Amyloid Peptides Promote Platelet Aggregation through the Coordinated Action of ITAM- and ROS-Dependent Pathways

C. Visconte¹, J. Canino², M. Vismara¹, L. Galgano², G. Pula³, G. Guidetti¹, M. Torti¹, I. Canobbio¹
Abstract Number: PB1173

Fibrin Clot Properties in Patients with Qualitative Fibrinogen Disorders: Data from the PRO-RBDD Cohort

A. Casini^1,2, R. Palla³, M. Menegatti⁴, M. Neerman-Arbez⁵, P. de Moerloose⁶, F. Peyvandi^3,4
Abstract Number: PB0721

Fibrin Deposition in Mouse Transfusion-Related Acute Lung Injury Via Coagulation or Fibrinolysis Dysfunction

Y. Yu, P. Jiang, P. Sun, N. Su, X. Yuan, F. Lin
Abstract Number: PB0135

Fibrin Deposits on Peritoneal Carcinomatosis Serves as a Niche for Cancer Cell Implantation and Dissemination. A Scanning Electron Microscopy Analysis

I. Aldybiat¹, S. Mirshahi^1,2, R. Kaci¹, C. Pimpie¹, M. Pocard¹, J. Soria¹, M. Mirshahi¹
Abstract Number: PB0823

Fibrin Polymerization Ability Is Variable in Patients with Severe Haemophilia and Might Influence their Joint Condition

I. Fernández-Bello¹, H. De La Corte-Rodríguez¹, P. Acuña-Butta¹, M. Álvarez-Román^1,2, M. Martín-Salces¹, I. Rivas-Pollmar¹, S. García-Barcenilla¹, T. Cebanu¹, N. Butta¹, V. Jiménez-Yuste^1,2
Abstract Number: OC 02.1

Fibrin γ-chain Crosslinking Plays an Important Role in Preventing Thrombus Breakdown and Embolisation in-vivo

C. Duval¹, A. Baranauskas¹, M. Ali¹, Z. Raslan¹, S.R. Baker¹, H.R. McPherson¹, M.A. Bailey¹, R.M. Cubbon¹, R.A. Ajjan¹, H. Philippou¹, K.K. Naseem¹, V.C. Ridger², R.A.S. Ariëns¹
Abstract Number: PB0713

Fibrinogen Concentrate Replacement Guided by Thromboelastometry Can Improve Clot Strenght in Adult Dengue with Severe Thrombocytopenia

T. Crochemore¹, F. Savioli²
Abstract Number: OC 02.4

Fibrinogen Is Citrullinated in Venous Thrombi and Forms Fragile Clots with Increased Resistance to Lysis

I. Varju^1,2,3, N. Sorvillo^2,4, D. Cherpokova^2,4, V.J. Farkas¹, A.Z. Farkas¹, E. Komorowicz¹, T. Feller⁵, B. Kiss⁵, M.S. Kellermayer⁵, L. Szabo⁶, A. Wacha⁷, A. Bota⁷, C. Longstaff⁸, D.D. Wagner^2,4,9, K. Kolev¹
Abstract Number: PB0557

Fibrinogen Prothrombin Time Derived Method Is Not Useful in Anticoagulated Patients with Apixaban

C. Duboscq¹, M. Martinuzzo^2,3, J. Ceresetto¹, M. Lopez^2,3, L. Barrera^2,3, J. Avila Rueda¹, J. Oyhamburu^2,3, G. Stemmelin¹
Abstract Number: PB0723

Fibrinogen Supplementation in Patients with Acquired Hypofibrinogenaemia: Meta-Analysis and Systematic Review

N. Rahe-Meyer¹, P. Collins², C. Fenger-Eriksen³, P. Innerhofer⁴, M. Fries⁵, M. Ranucci⁶
Abstract Number: PB0654

Fibrinolysis Detection by TEG and ROTEM Viscoelastic Analysers: An in vitro Comparison

J. Dias¹, E. Shafizadeh², J. Leiriao², J. Hartmann²
Abstract Number: PB2002

Fibrinolytic Activity in Patients with Granulomatosis with Polyngiitis (GPA)

T. Iwaniec¹, J. Musiał², L. Zaręba³, M. Celińska-Lowenhoff²
Abstract Number: PB1203

Fibrinolytic Alterations in a Thrombomodulin-associated Coagulopathy Are Diminished by Coinheritance of a TAFI Mutation

C.S. Whyte¹, S. Westbury², R.C. Tait³, N.J. Mutch¹, K. Downes⁴, J. Mertens⁵, K. Claesen⁵, D. Hendriks⁵, E. Leishman³, A. Mumford², NIHR BioResource
Abstract Number: PB0736

Fibrinolytic Response Plays a Central Role in Trauma Induced Coagulopathy

H. Kwaan¹, M. Walsh²
Abstract Number: PB0541

FIBTEM Parameters Correlate Well with the Fibrinogen Concentration Measured by the Clauss Assay in Patients and Healthy Subjects

J.J. de Vries, C.J.M. Snoek, C.S.B. Veen, M.J.H.A. Kruip, M.P.M. de Maat
Abstract Number: OC 03.2

Final Results of PUPs A-LONG Study: Evaluating Safety and Efficacy of rFVIIIFc in Previously Untreated Patients with Haemophilia A

C. Königs¹, M.C. Ozelo², A. Dunn³, R. Kulkarni⁴, B. Nolan⁵, S.A. Brown⁶, R. Liesner⁷, M. Schiavulli⁸, S. Gunawardena⁹, S. Mukhopadhyay¹⁰, D. Jayawardene⁹, B. Winding¹¹, M. Carcao¹²
Abstract Number: PB0956

Final Results of PUPs B-LONG Study: Evaluating Safety and Efficacy of rFIXFc in Previously Untreated Patients with Haemophilia B

B. Nolan¹, A. Klukowska², A. Shapiro³, A. Rauch⁴, M. Recht⁵, M. Ragni⁶, J. Curtin⁷, S. Gunawardena⁸, S. Poloskey⁸, D. Jayawardene⁸, B. Winding⁹, K. Fischer¹⁰, R. Liesner¹¹
Abstract Number: PB0918

Final Safety Outcomes Following ≥5 Years’ Observation of BAY 94-9027 Treatment in Patients with Hemophilia A in the PROTECT VIII Extension

J. Oldenburg¹, J.M. Ducore², C. Tarango³, M.L. Simpson⁴, M. Wang⁵, M. Maas Enriquez⁶, S. Lalezari⁷
Abstract Number: PB1717

Finding the “Switch” in Platelet Activation – Prediction of Key Mediators Involved in the Reversal of Platelet Activation Using a Network Biology Approach

T.P. Lemmens¹, D.M. Coenen¹, I.C.L. Niessen¹, S.L.M. Coort², R.R. Koenen¹, M. Kutmon^2,3, J.M.E.M. Cosemans¹
Abstract Number: PB0865

Finding the Efficacy of Low Dose Prophylactic Regimen in Children Diagnosed with Severe Hemophilia

A. Fatima
Abstract Number: PB1451

First Autosomal Recessive Variant in TUBB1 Impairs Proplatelet Formation and Results in Inherited Macrothrombocytopenia

V. Palma-Barqueros¹, L. Bury², N. Bohdan³, J.M. Bastida⁴, A. Rodriguez-Alen⁵, J.F. Ruiz-Pividal³, N. Revilla³, A. Marin-Quilez⁴, V. Vicente³, M.L. Lozano³, P. Gresele², J. Rivera³
Abstract Number: PB2553

First Direct Evidence in Humans of a Severe Antithrombin Defect Causing Embryonic Lethality

C. Bravo-Perez¹, A. Palomo², L. Entrena³, M.E. de la Morena-Barrio¹, B. de la Morena-Barrio¹, J. Padilla¹, A. Miñano¹, V. Vicente¹, J. Corral¹
Abstract Number: PB0994

First Episode of Macroscopic Hematuria in Hemophilia: Causes and Treatment

G. Mulders¹, L.G.R. Romano¹, S.C.M. Stoof¹, I. van Moort², M.B. Busstra³, F.W.G. Leebeek¹, M.J.H.A. Kruip¹
Abstract Number: PB0243

First Evaluation of the Safety, Pharmacokinetics and Pharmacodynamics of BAY 2433334 a Small Molecule Targeting Coagulation Factor XIa in Healthy Young Male Participants

D. Thomas¹, F.S. Kanefendt¹, S. Schwers¹, S. Unger¹, A. Yassen¹, S. Boxnick²
Abstract Number: PB1483

First Evidence: Edoxaban Affects TRAP-dependent Platelet Aggregation

L. Vadelova¹, J. Sokol², F. Nehaj³, J. Ivankova², M. Mokan³, I. Plamenova², J. Zolkova², J. Stasko²
Abstract Number: PB1482

First Evidence: Rivaroxaban, Apixaban and Edoxaban Reduce Thrombin-Dependent Platelet Aggregation

J. Sokol¹, F. Nehaj², M. Mokan², J. Ivankova¹, L. Lisa¹, J. Zolkova¹, L. Vadelova¹, J. Stasko¹
Abstract Number: OC 03.4

First In Human Liver Biopsy Study Following Gene Therapy for Hemophilia A

S. Fong¹, S. Rangarajan², N. Mitchell¹, C.-R. Sihn¹, B. Yates¹, R. Torres¹, C. Russell¹, K.J. Pasi³, A. Lawal¹, B. Kim¹, S. Bunting¹, G. Pierce⁴, W.Y. Wong¹
Abstract Number: PB0952

First Interim Analysis of a 24-Month, Prospective, Non-Interventional, Multicentre Study in Germany Evaluating the Real-World Usage and Effectiveness of rFVIIIFc and rFIXFc in Patients with Haemophilia A or B (PREVENT)

C. Bidlingmaier¹, C. Heller², K. Schilling³, F. Langer⁴, W. Miesbach⁵, J. Oldenburg⁶, U. Scholz⁷, J. van den Boom⁸, H. Malmström⁹, B. Winding⁹, A. Tiede¹⁰
Abstract Number: PB1730

First novel Pathogenic Variant in ITGA2B in a Ecuatorian Patient with Glanzmann Thrombasthenia

N. Bermejo¹, J.M. Bastida², B. Moriano¹, M. Espina¹, F. Ibáñez¹, R. Benito³, A. Marín-Quílez³, O. Ferré¹, M.J. Arcos¹, H. Bañas¹
Abstract Number: PB1428

First Performance Data of a New Latex Enhanced Immunoassay to Detect HIT Antibodies in Plasma Samples *

M. Ehm, G. Christ, H. Schwarz, F. Vitzthum, N. Zander
Abstract Number: PB1370

First Report of Rituximab Dependent Anti-platelet Antibodies as Cause of Acute Thrombocytopenia

Y. Kong¹, R. Wong², I. Tohidi-Esfahani¹, M. Konda¹, I. Cunningham¹, J. Estell¹, B.H. Chong², V. Chen¹
Abstract Number: OC 09.4

First-in-Human Gene Therapy Study of AAVhu37 Capsid Vector Technology in Severe Hemophilia A: Safety and FVIII Activity Results

S.W. Pipe¹, C.R.M. Hay², J. Sheehan³, T. Lissitchkov⁴, F.W.G. Leebeek⁵, M. Coppens⁶, E. Detering⁷, S. Ribeiro⁷, K.M. Vanevski⁷
Abstract Number: PB0196

First-in-Human Study to Assess the Safety, Pharmacokinetics and Pharmacodynamics of ONO-7684, an Oral Small Molecule Factor XIa Inhibitor in Healthy Subjects

D. Beale¹, J. Dennison², K.-M. Chavele¹, K. Yoneda¹, P. Smith¹, M. Bruce¹
Abstract Number: PB2566

Five Years of Evaluation of Postpartum Haemorrhage in a Tertiary Portuguese Hospital

S. Ferreira, F. Santos, A. Ferreira, C. Silva, E. Cruz, F. Leite, M. Coutinho, G. Buchner, M. Amil, J. Braga, S. Morais, J. Coutinho
Abstract Number: PB0883

FⅨa-Triggered Thrombin Generation Assay for Monitoring Very Low Levels of FⅧ Activity in Hemophilia A

M.J. Huang¹, J. Gantioqui², H. Atkinson³, A.A.K. Chan⁴, H.H.W. Chan⁵
Abstract Number: PB2389

Fixed Dose Rivaroxaban Can Be Prescribed in Extremes of Bodyweight, Results of a Population Pharmacokinetic Analysis

V. Speed^1,2, B. Green³, L. Roberts¹, S. Woolcombe⁴, J. Bartoli-Abdou¹, S. Barsam¹, R. Byrne¹, E. Gee¹, J. Czuprynska¹, A. Brown¹, S. Duffy¹, B. Vadher¹, R. Patel¹, V. Scott¹, A. Gazes¹, R. Patel¹, R. Arya¹, J. Patel^1,2
Abstract Number: PB1444

Flow Cytometry of Platelets: A Way for Distinguishing Patients with MYH9-related Disease from Patients with Other Inherited Thrombocytopenias and Immune Thrombocytopenia

D. Fedorova¹, A. Ignatova¹, D. Polokhov¹, E. Ponomarenko¹, M. Panteleev², P. Zharkov¹
Abstract Number: PB0463

FM and D-di in Preeclampsia and in vitro Fertilization

T. Vavilova¹, V. Vlasov¹, I. Zazerskaya², A. Godzoyeva², O. Kozina³
Abstract Number: PB0062

Folate Exchange in Athletes of North-West Russia

N. Vorobyeva¹, N. Malishkina²
Abstract Number: PB1872

Follow-up Evaluation of Patients with Hereditary Thrombotic Thrombocytopenic Purpura (hTTP) from the International Hereditary TTP Registry: Incidence of Acute Disease Episodes with or without Regular Prophylactic Plasma Infusions

E. Tarasco^1,2, L. Bütikofer³, G. Sinkovits⁴, Z. Prohászka⁴, A.S. von Krogh⁵, P.N. Knöbl⁶, K.D. Friedman⁷, J.N. George⁸, I. Aebi-Huber^1,2, K.A. Jalowiec¹, Z. Cermakova⁹, M. Górska-Kosicka¹⁰, J. Windyga¹⁰, I. Hrachovinova¹¹, C.R. Largiadèr¹², M. Matsumoto¹³, B. Lämmle^1,14, J.A. Kremer Hovinga^1,2
Abstract Number: PB2157

Fondaparinux versus Enoxaparin in the Treatment of Venous Thromboembolism in Cancer Patients: Retrospective Cohort Study – “ONCOTEV”

B. Abbate, A. Dalla Salda, E. Spaggiari, L. Depietri, M. Iotti, I. Lambertini, S. Corradini, M.R. Veropalumbo, A. Ghirarduzzi
Abstract Number: OC 13.1

Force-induced Unfolding of the Autoinhibitory Module Activates VWF

N. Arce¹, W. Cao², A. Brown³, E. Legan¹, M. Wilson¹, J. Emsley³, F. Zhang², R. Li¹
Abstract Number: PB1358

Fostamatinib as Second-Line Therapy for ITP and in Earlier Stage ITP Patients

W. Ghanima^1,2, N. Cooper³, R. Boccia⁴, M. Boxer⁵, Q. Hill⁶, M. Sholzberg⁷, M. Tarantino⁸, Y. Kreychman⁹, V. Markovtsov¹⁰, S. Tong¹¹, J. Bussel¹²
Abstract Number: PB1088

Frequency, Location and Nature of AAV Vector Insertions After Long-Term Follow up of FVIII Transgene Delivery in a Hemophilia A Dog Model

P. Batty¹, S. Fong², M. Franco³, I. Gil-Farina³, A.M. Mo¹, L. Harpell¹, C. Hough¹, D. Hurlbut¹, A. Pender¹, S. Sardo Infirri¹, A. Winterborn⁴, M. Schmidt³, D. Lillicrap¹
Abstract Number: PB1818

From the Antiplatelet Drug Ticagrelor to New Antibiotics

N. Jacques¹, E. Goffin², L. Musumeci¹, P. Lancellotti^1,3,4, C. Oury¹
Abstract Number: PB1943

Fulminant Pulmonary Tumor Thrombotic Microangiopathy (PTTM) in a Young Man: Clinical and Immunoistochemical Characterization of a Rare Complication of Gastric Signet Ring Cell Carcinoma

R. Rossio¹, E. Pagliaro¹, A. Artoni¹, M.C. Mocellin², G. Lopez³, F. Peyvandi^1,4
Abstract Number: PB0987

FVIII Assay and APTT Results on Obizur in-vitro Spiked Plasma Samples: Analysis from the First UK National External Quality Assurance Scheme for Blood Coagulation (UK NEQAS BC) Obizur Exercise

A. Lowe, S. Kitchen, I. Jennings, D. Kitchen, L. Brown, S. Munroe-Peart, I. Walker
Abstract Number: PB0328

FVIII Gene Mutation Analysis and Evaluation of Clinical Data: One Center Result

A. Meral Gunes¹, M. Sezgin Evim¹, B. Baytan¹, T. Atik², S. Güler³
Abstract Number: PB1185

FXI Gene Mations in Northern Region of Turkey

C. Albayrak¹, D. Albayrak², H. Gürkan³
Abstract Number: PB1929

FXI Levels as Independent Risk Factor for Antiphospholipid Syndrome: Development of a New Predictive Score, APS-FXI

M.E. de la Morena-Barrio¹, J. Pagan-Escribano², A. Miñano¹, V. Roldán¹, A. Lopez-Arribas³, J. Lozano², M.J. Hernandez-Vidal², I. de la Morena-Barrio⁴, V. Vicente¹, M.T. Herranz², J. Corral¹
Abstract Number: OC 02.3

FXIII Catalyses Histone-Fibrin Crosslinking to Inhibit Fibrinolysis

M. Locke, C. Longstaff